Objective To systematically review the clinical efficacy of thunder moxibustion combined with other therapies in the treatment of periarthritis humeroscapularis. Methods Articles of randomized controlled trials (RCTs) on the effect of thunder moxibustion combined with other therapies in the treatment of periarthritis humeroscapularis were searched from the inception of the databases to May 2023 across the following databases: CNKI, Chinese biomedical literature database, Wanfang, VIP, PubMed, Cochrane Library, Embase, and Web of Science. Two researchers independently screened the articles and collected the data. The risk of bias assessment tools recommended in the Cochrane handbook was used to analyzed risk of bias, and RevMan5.4 software was applied to perform a Meta-analysis on the included articles′ data. Results Eight RCTs involving 636 patients were included. The results of Meta-analysis showed that compared with the control group, the overall effective rate (OR=5.36, 95%CI [3.05, 9.43], P<0.05) and the Constant-Murley score of shoulder range of motion (MD=10.00, 95%CI [8.79, 11.22], P<0.05) of the observation group were higher, and the Visual Analogue Scale score for pain was lower (MD=-1.55, 95%CI [-2.33, -0.77], P<0.05). None of the included studies reported adverse effects. Conclusion Thunder moxibustion combined with other therapies in the treatment of periarthritis humeroscapularis can improve the total effective rate of treatment, relieve pain, and improve the range of motion of the shoulder joint, which is relatively safe.

无